A detailed history of Pathstone Holdings, LLC transactions in Boston Scientific Corp stock. As of the latest transaction made, Pathstone Holdings, LLC holds 124,432 shares of BSX stock, worth $11.3 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
124,432
Previous 124,262 0.14%
Holding current value
$11.3 Million
Previous $9.57 Million 8.97%
% of portfolio
0.05%
Previous 0.04%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$72.96 - $84.0 $12,403 - $14,280
170 Added 0.14%
124,432 $10.4 Million
Q2 2024

Aug 14, 2024

BUY
$67.33 - $77.71 $498,107 - $574,898
7,398 Added 6.33%
124,262 $9.57 Million
Q1 2024

May 13, 2024

SELL
$57.6 - $68.62 $432,979 - $515,816
-7,517 Reduced 6.04%
116,864 $8 Million
Q4 2023

Feb 14, 2024

BUY
$48.64 - $57.81 $6.05 Million - $7.19 Million
124,381 New
124,381 $7.19 Million

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $130B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Pathstone Holdings, LLC Portfolio

Follow Pathstone Holdings, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pathstone Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pathstone Holdings, LLC with notifications on news.